MedPath

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion

Recruiting
Conditions
Peripheral Arterial Disease
Registration Number
NCT05894460
Lead Sponsor
Xuanwu Hospital, Beijing
Brief Summary

This study will assess the safety and efficacy of Chocolate balloons as a combination with drug-coated balloons in the treatment of popliteal artery lesions in lower limb atherosclerotic occlusive disease and will compare them with conventional balloons.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
254
Inclusion Criteria
  • Rutherford classification of 2-6 in patients with femoropopliteal atherosclerotic occlusive disease;
  • primary cases with no previous surgical treatment of the target lesion;
  • presence of at least one vessel with patency in the distal outflow tract;
  • survival >1 year.
Exclusion Criteria
  • planned stenting;
  • presence of flow-limiting dissection prior to application of Chocolate balloon and conventional balloon dilation of the target lesion;
  • combination of severe organ dysfunction of the heart, lungs and brain that cannot tolerate the procedure;
  • allergy to contrast agents, anaesthetic drugs, anticoagulants and anti-platelet drugs;
  • ineffective recanalization attempts;
  • lesions within or adjacent to the aneurysm, or the presence of a popliteal aneurysm.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary patency12 months

No occlusion or restenosis (\>50%) of the target vessel in the treated segment during follow-up and no further intervention is required.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Xuanwu Hospital

🇨🇳

Beijing, None Selected, China

Xuanwu Hospital
🇨🇳Beijing, None Selected, China
Zhu Tong
Contact
13522419980
tongzhuxw@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.